Menlo Park, CA
GRAIL, Inc. operates as a biotechnology company. The Company focuses on combining science, technology, and clinical studies to reveal cancer at its beginings. GRAIL offers its services in the United States.
https://grail.comThese are collections Grail is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$325,000,000
Post Ipo Equity
$110,000,000
IPO
Unknown
Series D
$390,000,000
Series C
$300,000,000
Series B
$1,214,655,040
Series A
$100,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Grail.